FdaApplication
NDA 213801
Identifiers
- fda_app_no: NDA213801
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA GLOBAL DEVELOPMENT INC |
| application_type | NDA |
| approval_date | 2021-03-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MYRBETRIQ GRANULES | MIRABEGRON | 8MG/ML | FOR SUSPENSION, EXTENDED RELEASE;ORAL |
1 product